Cell And Gene Therapy Logistics Requires Early Planning
Cell And Gene Therapy Logistics Requires Early Planning
$131.00
Traditionally, the subject of logistics has not been considered until late in the development process for cell and gene therapy. Industry experts at the October 2018 Cell and Gene Meeting on the Mesa in San Diego suggest that considering logistics early in the planning stages for cell and gene therapy is a critically important move.
Publisher: InVivo
- Description
Logistics for getting cell and gene therapies to patients quickly and efficiently is something that should be considered earlier, rather than later, in the development process, according to industry experts who met in October of 2018 at the Alliance for Regenerative Medicine’s (ARM) Cell and Gene Meeting on the Mesa. Experts gathered in San Diego to discuss the importance of considering logistics early on in the development process, as cell and gene therapy gain in popularity and prominence. Explore the findings of this meeting in this eye-opening In Vivo article.
© Pharma Intelligence UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
Father of Humira, Greg Winter, Wins 2018 Nobel Prize For Chemistry 
Sign up to the